Name
CLINICAL OUTCOMES AND DRUG SUSTAINABILITY AFTER NON-MEDICAL SWITCH FROM USTEKINUMAB ORIGINATOR TO BIOSIMILARS IN INFLAMMATORY BOWEL DISEASE
Topic
Inflammatory Bowel Diseases: Mechanisms and Treatments
Group
CDDW
Number
A282
Presenter
Justin Kritzinger
Poster Session
Poster Session II
Date
Saturday, February 28th 2026
Time
18h00-19h00